LASE Innovation is an early-stage company based near Boston, MA that is focused on solving complex biological problems and diseases by providing access to high-dimensional biological data. The Company is commercializing laser particle (LP) technology, novel optical probes for identifying and tracking millions of individual cells. LASE is developing cellular analysis instruments and LP barcoding reagents that enable unprecedented measurements of single cells over time and across platforms to acquire complete data from each cell, at scale. LASE Innovation is originally a spin-off from a Harvard Medical School / Massachusetts General Hospital lab where the core IP is exclusively licensed. The Company expects to launch its first products for its beachhead flow cytometry market by 2024 and is currently testing prototypes with external users, with a focus on immunology and immunotherapy applications.
Speaker
